Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Schizophrenia

A point of disruption

Nature volume 458, pages 976–977 (2009)Cite this article

Much is still to be learned about the molecular basis of mental disorders. The identification of a signalling pathway that is affected in schizophrenia, and which thus provides potential therapeutic targets, is a welcome advance.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Potential role of GSK3β and DISC1 in mental disorders.

References

  1. Ross, C. A., Margolis, R. L., Reading, S. A., Pletnikov, M. & Coyle, J. T. Neuron 52, 139–153 (2006).

    Article  CAS  Google Scholar 

  2. Lewis, D. A., Hashimoto, T. & Volk, D. W. Nature Rev. Neurosci. 6, 312–324 (2005).

    Article  CAS  Google Scholar 

  3. Harrison, P. J. & Weinberger, D. R. Mol. Psychiatry 10, 40–68 (2005).

    Article  CAS  Google Scholar 

  4. Camargo, L. M. et al. Mol. Psychiatry 12, 74–86 (2007).

    Article  CAS  Google Scholar 

  5. Mao, Y. et al. Cell 136, 1017–1031 (2009).

    Article  CAS  Google Scholar 

  6. Millar, J. K. et al. Hum. Mol. Genet. 9, 1415–1423 (2000).

    Article  CAS  Google Scholar 

  7. Chubb, J. E. et al. Mol. Psychiatry 13, 36–64 (2008).

    Article  CAS  Google Scholar 

  8. Kamiya, A. et al. Nature Cell Biol. 7, 1167–1178 (2005).

    Article  Google Scholar 

  9. Sawa, A. & Snyder, S. H. Science 310, 1128–1129 (2005).

    Article  CAS  Google Scholar 

  10. Duan, X. et al. Cell 130, 1146–1158 (2007).

    Article  CAS  Google Scholar 

  11. Faulkner, R. L. et al. Proc. Natl Acad. Sci. USA 105, 14157–14162 (2008).

    Article  ADS  CAS  Google Scholar 

  12. Lie, D. C. et al. Nature 437, 1370–1375 (2005).

    Article  ADS  CAS  Google Scholar 

  13. Jope, R. S. & Roh, M. S. Curr. Drug Targets 7, 1421–1434 (2006).

    Article  CAS  Google Scholar 

  14. Beaulieu, J. M., Gainetdinov, R. R. & Caron, M. G. Trends Pharmacol. Sci. 28, 166–172 (2007).

    Article  CAS  Google Scholar 

  15. Scolnick, E. M. Biol. Psychiatry 59, 1039–1045 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Christopher A. Ross is in the Departments of Psychiatry, Neurology and Neuroscience, and in the Program in Cellular and olecular Medicine.,

    Christopher A. Ross

  2. Russell L. Margolis is in the Departments of Psychiatry and Neurology, and in the Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. caross@jhu.edu,

    Russell L. Margolis

Authors
  1. Christopher A. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Russell L. Margolis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ross, C., Margolis, R. A point of disruption. Nature 458, 976–977 (2009). https://doi.org/10.1038/458976a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/458976a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing